Golestan University of Medical Sciences Repository

Items where Author is "Agah, S."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 2.

Merat, S. and Sharifi, A.-H. and Poustchi, H. and Hajiani, E. and Gharavi, A. and Karimi, J. and Mansour-Ghanaei, F. and Fattahi, M.-R. and Ahmadi, L. and Somi, M.-H. and Kalantari, H. and Ghadir, M.-R. and Sheikhesmaeili, F. and Baniasadi, N. and Sohrabi, M. and Moosavy, S. and Ziaee, M. and Zahedi, M.-J. and Mokhtare, M. and Sali, S. and Sayad, B. and Afshar, B. and Bakhshipour, A. and Parsi, A. and Sharifian, A. and Amiriani, T. and Malekzadeh, Z. and Merat, D. and Ganji, A. and Rahmani-Samani, F. and Jamali, R. and Sofian, M. and Ghezlou, M. and Sohrabpour, A.A. and Goshayeshi, L. and Valizadeh-Toosi, S.-M. and Eslami, L. and Maleki, I. and Hormati, A. and Shayesteh, A.-A. and Shayesteh, E. and Norouzi, A. and Abna, Z. and Janbakhsh, A. and Fakheri, H. and Minakari, M. and Sardarian, H. and Ghajary, A.F.A. and Fattahi-Abdizadeh, M. and Latifnia, M. and Roozbeh, F. and Agah, S. and Fakhrieh-Asl, S. and Nateghi-Baygi, A. and Fattahi, B. and Nateghi-Baygi, H. and Hill, A. and Malekzadeh, R. (2021) Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73 (1). p. 172.

Poustchi, H. and Majd Jabbari, S. and Merat, S. and Sharifi, A.-H. and Shayesteh, A.A. and Shayesteh, E. and Minakari, M. and Fattahi, M.R. and Moini, M. and Roozbeh, F. and Mansour-Ghanaei, F. and Afshar, B. and Mokhtare, M. and Amiriani, T. and Sofian, M. and Somi, M.-H. and Agah, S. and Maleki, I. and Latifnia, M. and Fattahi Abdizadeh, M. and Hormati, A. and Khoshnia, M. and Sohrabi, M. and Malekzadeh, Z. and Merat, D. and Malekzadeh, R. (2020) The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment. Journal of Gastroenterology and Hepatology (Australia).

This list was generated on Sun Nov 28 00:27:23 2021 IRST.